OMEGAVEN

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Croatia, Estonia, France, Hong Kong SAR China, Israel, Lithuania, New Zealand, Poland, Romania, Turkey.

Active ingredients

The drug OMEGAVEN contains one active pharmaceutical ingredient (API):

1	Omega-3-acid ethyl esters UNII XGF7L72M0F - FISH OIL
	Read more about Omega-3-acid ethyl esters

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OMEGAVEN Emulsion for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	509501501156418, 509501502152416, 509515080029403, 509520050027307
EE	Ravimiamet	1115198, 1115200, 1115884, 1115895
FR	Base de données publique des médicaments	65680455
HK	Department of Health Drug Office	49704
HR	Agencija za lijekove i medicinske proizvode	HR-H-890644326
IL	מִשְׂרַד הַבְּרִיאוּת	7996
LT	Valstybinė vaistų kontrolės tarnyba	1011778, 1011779
NZ	Medicines and Medical Devices Safety Authority	11013
PL	Rejestru Produktów Leczniczych	100099188
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W12774001, W12774002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699630697272
US	FDA, National Drug Code	63323-205